BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

24 related articles for article (PubMed ID: 1282853)

  • 1. Cross-reactive T cell clones from unrelated individuals reveal similarities in peptide presentation between HLA-B27 and HLA-DR2.
    López D; Barber DF; Villadangos JA; López de Castro JA
    J Immunol; 1993 Apr; 150(7):2675-86. PubMed ID: 7681078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure and diversity of HLA-B27-specific T cell epitopes. Analysis with site-directed mutants mimicking HLA-B27 subtype polymorphism.
    Calvo V; Rojo S; López D; Galocha B; López de Castro JA
    J Immunol; 1990 May; 144(10):4038-45. PubMed ID: 1692072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of binding pockets for amino-terminal peptide residues in HLA-B27 allorecognition.
    Villadangos JA; Galocha B; López D; Calvo V; López de Castro JA
    J Immunol; 1992 Jul; 149(2):505-10. PubMed ID: 1378067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unusual topology of an HLA-B27 allospecific T cell epitope lacking peptide specificity.
    Villadangos JA; Galocha B; López de Castro JA
    J Immunol; 1994 Mar; 152(5):2317-23. PubMed ID: 7510742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation on immunogenicity by HLA-B27 subtype polymorphism.
    Jaraquemada D; Galocha B; Aparicio P; Rojo S; Calvo V; López de Castro JA
    Eur J Immunol; 1988 Dec; 18(12):1945-50. PubMed ID: 2464494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptide-mediated allo-recognition of HLA-B27 by cytotoxic T lymphocytes.
    Rojo S; López de Castro JA
    Int J Cancer Suppl; 1991; 6():10-3. PubMed ID: 1712346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure and immune recognition of HLA-B27 antigens: implications for disease association.
    López de Castro JA; Bragado R; Lauzurica P; López D; Rojo S
    Scand J Rheumatol Suppl; 1990; 87():21-31. PubMed ID: 1701918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-B27 and HLA-A2 subtypes: structure, evolution and function.
    López de Castro JA
    Immunol Today; 1989 Jul; 10(7):239-46. PubMed ID: 2679637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysfunction of HLA-B27.
    Ivanyi P
    Scand J Rheumatol Suppl; 1990; 87():51-69; discussion 69. PubMed ID: 2259889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigenic mimicry and autoimmune diseases.
    Nickerson C; Luthra H; David C
    Int Rev Immunol; 1991; 7(3):205-24. PubMed ID: 1721932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the substitution of critical residues on the allorecognition of HLA-B27.
    Ozen S; Clayberger C; Krensky AM; Benjamin R
    Clin Exp Rheumatol; 1992; 10(6):583-7. PubMed ID: 1282853
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.